期刊文献+

托吡酯单用及合并用药治疗各型癫癎的疗效观察 被引量:4

暂未订购
导出
摘要 目的 观察托吡酯 (TPM)单用及合并用药治疗各种类型癫疒间 的临床疗效、不良反应及有效剂量。方法 对 87例各种类型的癫疒间患者进行TPM单药 (4 8例 )、合并用药 (39例 )治疗。TPM从小剂量开始 ,起始量儿童≤ 2 0kg者为 6 .2 5mg/d ,>2 0kg者为 12 .5mg/d ,成人为 2 5mg/d ,根据抽搐控制情况调整药物剂量并观察疗效及不良反应。结果 单药治疗有效率为 79.2 % ,平均有效维持剂量为 (10 3.9± 78.5 )mg/d ;合并用药治疗有效率为 76 .9% ,平均有效维持剂量为 (172 .5± 10 5 .7)mg/d。除 1例因严重胃肠道反应而终止治疗外 ,其余不良反应症状轻微且短暂 ,多发生于加药期。结论 TPM单用及合并用药治疗各型癫疒间 均有效 ,不良反应少 。
出处 《临床神经病学杂志》 CAS 2003年第4期241-242,共2页 Journal of Clinical Neurology
  • 相关文献

参考文献5

二级参考文献16

  • 1王学嶂,沈鼎烈.卡马西平、苯妥英钠的耐受性研究[J].临床神经病学杂志,1993,6(4):226-228. 被引量:8
  • 2王学峰.丙戊酸镁的良性和不良耐受性[J].新药与临床,1993,12(5):289-290. 被引量:5
  • 3[1]Baker GA,Jacoby A,Buck D,et al.Quality of life of people w ith epilepsy:a European stady[J].Epilepsia,1997,38∶353-362.
  • 4[2]Coulter DA,Sombati S,Deloernzo RJ,et al.Selective effects of topir amate on sustained repetitive firing and spontaneous bursting in cultured hippoc ampal nrurons[J].Epilepsia,1993,34(Suppl 2)∶123-126.
  • 5[1]Reife R, Pledger G, Wu S. Topiramate as add-on therapy :pooled analysis of randomized controlled trials in adults. Epilepsia, 2000, 41(suppl 1): 66
  • 6[3]Sachdeo RC, Reife RA, Lim P, et al. Topiramate monotherapy for partial onset seizure. Epilepsia, 1997, 38: 294
  • 7[4]Faught E, Wilder BJ, Ramsay J, et al. Topiramate placebo-controlled dose-ranging trial in refractory partialepilepsy using 200-, 400-, 600 mg daily dosages. Neurology, 1996, 46: 1684
  • 8[5]Ritter F, Glauser TA, Elterman RD,et al. Effectiveness, tolerability, and safety of topiramate in children with partial-onset seizures. Epilepsia, 2000, 41(suppl 1): 82
  • 9[6]Severt L, Coulter DA, Sombati S, et al. Topriamate selectively blocks kainate currents in cultured hippocampal neurons. Epilepsia, 1995, 36(suppl 4): 38
  • 10So E L,Ann Neurol,1994年,35卷,743页

共引文献39

同被引文献29

  • 1唐嶂龙,唐健.癫痫1184例临床分析及随访研究[J].中华全科医学,2003,5(2):109-110. 被引量:8
  • 2Zhang XL, Velumian A, Jones OT, et al. Modulation of high voltage-activated calcium channels in dentate grannel cells by topiramate[J]. Epilepsia, 2000, 41(Suppl 1): S52.
  • 3Barrera MN. Characteristics and indications of topiramate [ J ]. Rev Neurol, 2002, 35 (Suppl 1 ): S88.
  • 4Racine RJ, Steingart M, Mcintyre DC. Development of kindlingprone and kindling-resistant rats: selective breeding and electrophysiological studies[J]. Epilepsy Res, 1999, 35: 183.
  • 5Smith-Swintosky VL, Zhao B, Shank RP, et al. Topiramate promotes neurite outgrowth and recovery of function after nerve injury[J]. Neuroreport, 2001, 12: 1031.
  • 6Niebauer M, Gruenthal M. Topiramate reduces neuronal injury after experimental status epilepticus[J]. Brain Res, 1999, 837: 263.
  • 7Edmonds HL, Jiang YD, Zhang PY, et al. Topiramate as a neuroprotectant in a rat model of global ischemia-induced neurodegeneration[ J]. Life Sci, 2001,69: 2265.
  • 8Cha BY, Silveira DC, Liu XZ, et al. Effect of topiramate following recurrent and prolonged seizures during early development[ J]. Epilepsy Res, 2002, 51: 217.
  • 9Kanda T, Kurokawa M, Tamura S, et al. Topiramate reduces abnormally high extracellular levels of glutamate and aspartate in the hippocampus of spontaneously epileptic rat ( SER ) [ J ]. Life Sci,1996, 59:1607.
  • 10White HS, Brown SD, Woodhead JH, et al. Topiramate enhances GABA-mediate flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold [ J ]. Epilepsiy Res,1997, 28: 167.

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部